Skip to main content
. 2020 Feb 28;15(9):1686–1700. doi: 10.4103/1673-5374.276340

Table 4.

Adverse events in the treatment group

Adverse events n(%) Corresponding treating measures
Intracranial infection No complications
Cerebrospinal fluid leakage No complications
Tumorigenesis No complications
Neurologic deterioration No complications
Constipation 6(30) Symptomatic treatment
Urinary system infection 5(25) Antibiotic injection
Pulmonary infection 4(20) Antibiotic injection
Psychological disorder 4(20) Psychological intervention
Osteoporosis 3(15) Medication therapy (alendronate sodium, calcium)
Pressure sores 2(10) Strengthening nursing, dressing change daily
Deep venous thrombosis 1(5) Anticoagulation and thrombolysis therapy